Diagnostic imaging deal sourcing firms, ranked.

The diagnostic imaging deal sourcing firms worth a shortlist in 2026 are a short list for a specific reason: imaging is one of the hardest healthcare sub-sectors to reach, and almost nobody in the category says so. Across 14,750 emails to diagnostic imaging owners in our owner response rates by sector research, only 0.5 owners per 1,000 said they were open to a conversation, roughly a tenth of health tech's rate in the same dataset, and it took 2,107 emails on average to find one. A fifth of the human replies, 22%, came from an administrator rather than the owner. None of the five generalist firms we checked name diagnostic imaging, radiology, or imaging centers anywhere on their own live sites, and our own healthcare sector coverage is what we run this vertical through when a client asks for it. We publish this list and DealSource Systems is our own service, so it is ranked first; the other five are ranked on fit, and every claim about them is quoted from that firm's own live website, read in this run, and linked as the source.

A buyer with an imaging thesis, whether a PE fund consolidating freestanding centers, a radiology group doing add-ons, or an advisor running sell-side mandate origination for an imaging owner who wants to sell, is choosing between firms that treat the sector as one line in a broad buy box. None specialise. That makes the choice less about who "knows imaging" and more about who can run a hard-to-reach sector properly.

Which diagnostic imaging deal sourcing firms actually specialise in the sector

None of them. Harvey & Company comes closest, listing "Healthcare Services" and "Medical Products" among 30-plus served sectors, but diagnostic imaging, radiology, and imaging centers appear nowhere on its site. The other four generalists do not name healthcare in any form at the sub-sector level, a narrower gap than the parent healthcare deal sourcing firms category shows, where healthcare itself at least gets a mention.

Quick comparison

How we chose this list

We only considered firms that run owner outreach for buy-side mandates, not directories that hand over a list and leave the calling to the buyer. Every firm below states, on its own site, that it works buy-side origination for private equity, independent sponsors, family offices, or M&A advisors, and we checked each specifically for whether diagnostic imaging, radiology, or imaging centers appear as a named focus. None were current DealSource Systems clients or partners at the time of writing.

DealSource Systems

Best for: PE firms, M&A advisors, boutique investment banks and search funds who need a sector worked properly rather than skimmed, because imaging owners do not reply to a generic approach.

DealSource Systems is the origination arm of Danish Lead Co. AI maps the market and scores readiness signals, and an operator with deal experience reviews every message before an owner sees it, described on how it works. Pricing starts from $4,000 a month for a single thesis, no success fee, 90-day minimum. Our published proof point is a healthcare investment bank client that reached 14 owner conversations in three weeks and 133 within 90 days, and the healthcare sub-sector data behind this post, including the imaging row, is broken out further in healthcare sell-side mandates.

Harvey & Company

Best for: well-capitalised funds and corporations running buy-and-build strategies at enterprise scale, where sector depth across 30-plus generalist industries matters more than an imaging-specific record.

Harvey & Company is a buy-side acquisition search and advisory firm headquartered in Newport Beach, California. Its site lists Healthcare Services and Medical Products among 30-plus served sectors and serves "well-capitalized private equity funds and corporations." No diagnostic imaging, radiology, or imaging centre claim appears on harveyllc.com, and pricing is not published. DealSource Systems vs Harvey & Company sets that scale against our thesis-driven model.

CAPTARGET

Best for: funds and advisors wanting volume outreach plus broker-market monitoring, where imaging is one of many buy boxes rather than a stated focus.

CAPTARGET runs off-market owner outreach for a stated "Private equity, Corporate development, Family offices, Independent sponsors, Search funds, Buy-side advisors" client base, headquartered in San Diego, citing "1,500+ clients served since 2009" with "No Fees for Originated Deals." No diagnostic imaging claim appears on captarget.com. DealSource Systems vs CAPTARGET weighs its success-fee model against our retainer.

SourceCo

Best for: buyers who want a matching platform across a defined revenue band rather than a fully managed outreach programme.

SourceCo uses AI and proprietary data to match founder-led companies in the "$2 million to $200 million" range with private equity, corporate development, search fund and family office buyers, with sellers paying nothing. Case studies on sourcecodeals.com lean residential services and automotive; no diagnostic imaging claim appears, and buyer pricing is not published. DealSource Systems vs SourceCo compares the matching model against an operator-run programme.

TruSight

Best for: funds and family offices wanting a steady subscription feed of proprietary opportunities without committing to a single sector thesis.

TruSight serves "professional investors, private equity funds, family office investors, and business intermediaries," with named clients including Blackstone, Alpine and Jordan Company on trusightllc.com. No headquarters, no named sectors, and no diagnostic imaging claim appear on the site, and buyer pricing is not published. DealSource Systems vs TruSight sets that sector-agnostic feed against a defined thesis.

Konverrt

Best for: an advisor or PE firm testing a diagnostic imaging thesis before committing to a full retainer.

Konverrt runs a "deal origination engine" for lower middle market M&A advisors and PE firms targeting owner-operated businesses in the $1 million to $50 million range, with "no invoice until your first two qualified seller meetings" land, then a few thousand dollars a month depending on programme scale. Named focuses on konverrt.com lean B2B SaaS and services; no diagnostic imaging claim or headquarters is published. DealSource Systems vs Konverrt is the closest read, since it sells the model nearest ours.

Why do diagnostic imaging owners reply so rarely

Mostly because the sector has been worked hard already, and because the person reading the email is often not the owner. Our healthcare sell-side mandates research splits healthcare into eight sub-sectors: diagnostic imaging's 0.5 open owners per 1,000 emails sits near the bottom, well below physical therapy at 2.0 and only just ahead of medical practices at 0.2, both categories that have also seen heavy roll-up activity. Imaging also carried a 25% do-not-contact share, about a third higher than the all-healthcare average of 19%, which reads as a sector that has heard from a lot of buyers already.

The 22% wrong-person share is the more fixable half of the problem. Imaging centers and radiology groups route general inquiries through practice administrators and office managers more than most owner-led businesses, so contact data built from a generic company email or a switchboard number finds the gatekeeper before it finds the owner. A deal sourcing firm that cannot tell the difference will report a reply rate that looks almost reasonable while producing almost no owner conversations.

How should a buyer choose between these diagnostic imaging deal sourcing firms

1. 1. Ask directly whether the firm has run an imaging mandate, and ask what share of its replies came from the actual owner versus an administrator. None of the five generalists here state an imaging track record on their own site, so a reference request is the only way to separate real experience from a buy box that happens to include healthcare.
2. 2. Decide whether you are buying or selling. The firms above run buy-side outreach; an imaging group going to market usually needs sell-side mandate origination run as a managed process, a distinction covered in sell-side vs buy-side origination.
3. 3. Price the volume against the sector's own response rate. At 2,107 emails per open owner, twenty conversations needs roughly 42,000 emails, far more than a sector like health tech at 205 per owner. Our owner outreach calculator runs that math for any sector.
4. 4. Push on contact data quality before volume. A firm that cannot explain how it verifies it has reached the owner, not the front desk, will inflate its reply numbers without producing more real conversations.

Several of these providers also work outside imaging, and how the main deal sourcing companies compare covers them on fee model and process more broadly. Buyers weighing imaging against other hard-to-reach categories may also want medical device company acquisitions and medical billing company acquisitions, two adjacent sourcing guides built the same way.

Conclusion

Diagnostic imaging is one of the harder healthcare sub-sectors to source in: owners reply less than almost anywhere else we measure, a meaningful share of what looks like a reply is an administrator, and the sector shows the fatigue signature of a category that has already been worked by roll-up buyers. The providers available to run that outreach are generalists who do not name the sector specifically, which makes contact data quality and a willingness to report the real numbers more important than a sector-specific pitch nobody can actually back up. Our own healthcare deal sourcing firms and urgent care acquisitions coverage look at adjacent categories if imaging is one thesis among several on your list.

If you would rather have this run for you, DealSource Systems does off-market deal sourcing for lower middle market private equity: owners reached directly before they run a process, for a flat $4,000 a month.

Key Terms Glossary

Frequently asked questions